Kwee L Yong (Kwee Yong)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 52

Top Topics

Stem Cell Transplantation

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

British journal of haematology

Blood cancer journal

Nature communications

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Catherine S Y Lecat, Eileen Mary Boyle, Daniel Hughes, Lydia S H Lee, Dean Smith, Ceri A Bygrave, Karthik Ramasamy, Kwee L Yong
Challenges in designing and running smouldering myeloma interventional clinical trials. EJHaem 5 (2) (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology (2024)
Binod Dhakal, Hermann Einsele, Jordan M Schecter, William Deraedt, Nikoletta Lendvai, Ana Slaughter, Carolina Lonardi, Sandhya Nair, Jianming He, Akshay Kharat, Patricia Cost, Satish Valluri, Kwee L Yong
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database. Blood advances (2024)
Daniel Hughes, Kwee L Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British journal of haematology 204 (4) (2024)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Annabel McMillan, Supratik Basu, Kamaraj Karunanithi, Elizabeth Parkins, Edward Yan Ming Lau, Gordon Cook, Christopher Parrish, Firas Al-Kaisi, Guy Pratt, Salim Shafeek, Stephen Jenkins, Danish Memon, Ceri A Bygrave, Xenofon Papanikolaou, Tara Maisel, Sandra Hassan, Shivir Moosai, Gurvin Chander, Pallav Rakesh, Bhuvan Kishore, Farheen Karim, Georgina Talbot, Farooq A Wandroo, Kwee L Yong, Rakesh Popat
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. British journal of haematology (2023)
Yeman B Hagos, Catherine S Y Lecat, Dominic Patel, Anna Mikolajczak, Simon P Castillo, Emma J Lyon, Kane Foster, Thien-An Tran, Lydia S H Lee, Manuel Rodriguez, Kwee L Yong, Yinyin Yuan
Deep learning enables spatial mapping of the mosaic microenvironment of myeloma bone marrow trephine biopsies. Cancer research (2023)
Orla McCourt, Abigail Fisher, Gita Ramdharry, Joanne Land, Anna L Roberts, Neil Rabin, Kwee L Yong
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial. Acta oncologica (Stockholm, Sweden) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Nuno Correia, Emma Dowling, Rakesh Popat, Neil Rabin, Chara Kyriakou, Jonathan Sive, Kwee L Yong, Ashutosh Wechalekar
Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma. British journal of haematology (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Parvathi Sudha, Aarif Ahsan, Timothy Cody Ashby, Tasneem Kausar, Akhil Khera, Mohammad H Kazeroun, Chih-Chao Hsu, Lin Wang, Evelyn Fitzsimons, Outi Salminen, Patrick Blaney, Magdalena Czader, Jonathan Williams, Mohammad Abu Zaid, Naser Ansari-Pour, Kwee L Yong, Frits van Rhee, William E Pierceall, Gareth J Morgan, Erin Flynt, Sarah Gooding, Rafat Abonour, Karthik Ramasamy, Anjan Thakurta, Brian A Walker
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Houfu Leng, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J Chavda, Daria Galas-Filipowicz, Hantao Lou, Adel Ersek, Emma V Morris, Erdinc Sezgin, Yi-Hsuan Lee, Yunsen Li, Ana Victoria Lechuga-Vieco, Mei Tian, Jian-Qing Mi, Kwee L Yong, Qing Zhong, Claire M Edwards, Anna Katharina Simon, Nicole J Horwood
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature communications 13 (1) (2022)
Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Anish Tailor, Kwee L Yong, Rakesh Popat, Neil Rabin, Charalampia Kyriakou, Jonathan Sive, Simona Degli Esposti, Daniel F P Larkin, Sarah Worthington, Alyse Hart, Emma Dowling, Nuno Correia, Ceri Bygrave, Andrzej Rydzewski, Krzysztof Jamroziak, Ashutosh D Wechalekar
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis. Blood cancer journal 12 (9) (2022)
Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun, Kubra Karagoz, Ann Polonskaia, Mirian Salazar, Evie Fitzsimons, Korsuk Sirinukunwattana, Selina Chavda, Maria Ortiz Estevez, Fadi Towfic, Erin Flynt, William Pierceall, Daniel Royston, Kwee L Yong, Karthik Ramasamy, Paresh Vyas, Anjan Thakurta
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma. Blood 140 (16) (2022)
Houfu Leng, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J Chavda, Daria Galas-Filipowicz, Hantao Lou, Adel Ersek, Emma V Morris, Erdinc Sezgin, Yi-Hsuan Lee, Yunsen Li, Ana Victoria Lechuga-Vieco, Mei Tian, Jian-Qing Mi, Kwee L Yong, Qing Zhong, Claire M Edwards, Anna Katharina Simon, Nicole J Horwood
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature communications 13 (1) (2022)
Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Jotham Marfil, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Ashutosh D Wechalekar, Rakesh Popat, Jonathan Sive, Charalampia Kyriakou, Ke Xu, Eleni Nastouli, Kwee L Yong, Neil Rabin
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination. Leukemia & lymphoma 63 (10) (2022)
Houfu Leng, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J Chavda, Daria Galas-Filipowicz, Hantao Lou, Adel Ersek, Emma V Morris, Erdinc Sezgin, Yi-Hsuan Lee, Yunsen Li, Ana Victoria Lechuga-Vieco, Mei Tian, Jian-Qing Mi, Kwee L Yong, Qing Zhong, Claire M Edwards, Anna Katharina Simon, Nicole J Horwood
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature communications 13 (1) (2022)
Houfu Leng, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J Chavda, Daria Galas-Filipowicz, Hantao Lou, Adel Ersek, Emma V Morris, Erdinc Sezgin, Yi-Hsuan Lee, Yunsen Li, Ana Victoria Lechuga-Vieco, Mei Tian, Jian-Qing Mi, Kwee L Yong, Qing Zhong, Claire M Edwards, Anna Katharina Simon, Nicole J Horwood
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature communications 13 (1) (2022)
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, Robert A Redd, Eileen Mary Boyle, Benny Zhitomirsky, Andrew J Dunford, Yu-Tzu Tai, Selina J Chavda, Cody Boehner, Carl Jannes Neuse, Mahshid Rahmat, Andrew T Hutchinson, Tineke Casneuf, Raluca Verona, Efstathis Kastritis, Lorenzo Trippa, Chip Stewart, Brian A Walker, Faith E Davies, Meletios- Athanasios Dimopoulos, Peter Leif Bergsagel, Kwee L Yong, Gareth J Morgan, François Aguet, Gad A Getz, Irene M Ghobrial
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications 13 (1) (2022)
Houfu Leng, Hanlin Zhang, Linsen Li, Shuhao Zhang, Yanping Wang, Selina J Chavda, Daria Galas-Filipowicz, Hantao Lou, Adel Ersek, Emma V Morris, Erdinc Sezgin, Yi-Hsuan Lee, Yunsen Li, Ana Victoria Lechuga-Vieco, Mei Tian, Jian-Qing Mi, Kwee L Yong, Qing Zhong, Claire M Edwards, Anna Katharina Simon, Nicole J Horwood
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease. Nature communications 13 (1) (2022)
Louise Ainley, Marquita Camilleri, Selina J Chavda, Annabel McMillan, Lydia Lee, Rakesh Popat, Francesca Sillito, Kwee L Yong
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progression. British journal of haematology (2021)
Wei Yee Chan, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Stephen Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Laura Clifton-Hadley, Neil Rabin, Roger G Owen, Rakesh Popat, Kwee L Yong, null null
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. British journal of haematology (2021)
Marquita Camilleri, Maria Cuadrado, Elizabeth Phillips, William Wilson, Richard Jenner, Gavin Pang, Sumaiya Kamora, Matthew Streetly, Rakesh Popat, Ceri A Bygrave, Roger Owen, James Cavenagh, Mike Chapman, Jonathan Sive, Lydia Eccersley, Michael Sheaff, Reuben Benjamin, Karthik Ramasamy, Curly T C M Morris, Andres Virchis, Selina J Chavda, Laura Clifton-Hadley, Marie Anne Scully, Kwee L Yong
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. British journal of haematology 193 (4) (2021)
Monica Ziff, Gabrielle Lawson, Dunnya De-Silva, Simon Cheesman, Charalampia Kyriakou, Shameem Mahmood, Xenofon Papanikolaou, Neil Rabin, Sajitha Sachchithananthan, Jonathan Sive, Ashutosh D Wechalekar, Kwee L Yong, Rakesh Popat
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Leukemia & lymphoma 62 (5) (2021)
Wei Yee Chan, Emilie Sanchez, Selina J Chavda, Catherine S Y Lecat, Louise Ainley, Ke Xu, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Charalampia Kyriakou, Jonathan Sive, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Lydia Lee, Eleni Nastouli, Kwee L Yong
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy. British journal of haematology 194 (5) (2021)
Lydia Sarah Hui Lee, Kwee L Yong
BCMA CARs in multiple myeloma: room for more? Blood 137 (21) (2021)
Simon James Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, Philip Vlummens, Kwee L Yong, Frank Campana, Marlène Inchauspé, Sandrine Macé, Marie-Laure Risse, Helgi van de Velde, Paul Gerard Richardson
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. British journal of haematology 194 (1) (2021)
Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J Chavda, Emma Dowling, Nuno Correia, Catherine S Y Lecat, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Jonathan Sive, Charalampia Kyriakou, Ashutosh Wechalekar, Rakesh Popat, Neil Rabin, Eleni Nastouli, Kwee L Yong, Ke Xu
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors. British journal of haematology (2021)
Rakesh Popat, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie D Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Steve Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Paul Smith, Laura Clifton-Hadley, Neil Rabin, Roger Owen, Kwee L Yong, null null
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. British journal of haematology 193 (3) (2021)
Marquita Camilleri, Thomas McGrath, William Wilson, Stuart J Ings, Jacqueline Horder, Fiona Newrick, Jonathan Sive, Xenofon Papanikolaou, Rakesh Popat, Charalampia Kyriakou, Kwee L Yong, Neil Rabin
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients. Leukemia & lymphoma 62 (12) (2021)
Oliver C Cohen, Faye Sharpley, Julian D Gillmore, Helen J Lachmann, Sajitha Sachchithanantham, Shameem Mahmood, Marianna Fontana, Carol J Whelan, Ana Martinez-Naharro, Charalampia Kyriakou, Neil Rabin, Rakesh Popat, Kwee L Yong, Simon Cheesman, Raakhee Shah, Philip N Hawkins, Ashutosh D Wechalekar
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis. British journal of haematology 189 (4) (2020)
Thomas Andrew Fox, Ethan Troy-Barnes, Amy A Kirkwood, Wei Y Chan, James W Day, Selina J Chavda, Emil A Kumar, Kate David, Oliver Tomkins, Emilie Sanchez, Marie Anne Scully, Asim Khwaja, Jonathan Lambert, Mervyn Singer, Claire Roddie, Emma C Morris, Kwee L Yong, Kirsty J Thomson, Kirit M Ardeshna
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'. British journal of haematology 191 (3) (2020)
Louise Ainley, Selina J Chavda, Nicholas Counsell, Simon Cheesman, Fiona Newrick, Jackie Horder, Charalampia Kyriakou, Xenofon Papanikolaou, Jonathan Sive, Lydia Lee, Ashutosh Wechalekar, Atul Mehta, Rakesh Popat, Neil Rabin, Kwee L Yong
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. British journal of haematology 192 (3) (2020)
Selina J Chavda, Rachael Pocock, Simon Cheesman, Kyung-Min Lee, Emma Dowling, Daniel J B Marks, Charalampia Kyriakou, Lydia Lee, Jonathan Sive, Ashutosh Wechalekar, Neil Rabin, Kwee L Yong, Rakesh Popat
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations. British journal of haematology 190 (5) (2020)
Thomas Andrew Fox, Ethan Troy-Barnes, Amy A Kirkwood, Wei Yee Chan, James W Day, Selina J Chavda, Emil A Kumar, Kate David, Oliver Tomkins, Emilie Sanchez, Marie Anne Scully, Asim Khwaja, Jonathan Lambert, Mervyn Singer, Claire Roddie, Emma C Morris, Kwee L Yong, Kirsty J Thomson, Kirit M Ardeshna
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy. British journal of haematology 191 (2) (2020)
Sarah Anne Bird, Charlotte Pawlyn, Susanna Nallamilli, Priya Sriskandarajah, Martin F Kaiser, Kwee L Yong, Rakesh Popat, Neil Rabin, Kevin D Boyd
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients. British journal of haematology 191 (5) (2020)
Catherine Atkin, Gulnaz Iqbal, Tim Planche, Guy Pratt, Kwee L Yong, Jill Wood, Kerry Raynes, Eric Low, Helen Higgins, Richard D Neal, Janet Dunn, Mark T Drayson, Stella Bowcock, null null, null null
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial. British journal of haematology 192 (6) (2020)
Nouf Alrasheed, Lydia Lee, Ehsan Ghorani, Jake Y Henry, Lucia Conde, Melody Chin, Daria Galas-Filipowicz, Andrew J S Furness, Selina J Chavda, Huw Richards, Dunnya De-Silva, Oliver C Cohen, Dominic Patel, Anthony Brooks, Manuel Rodriguez-Justo, Martin Pule, Javier Herrero, Sergio A Quezada, Kwee L Yong
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Marquita Camilleri, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, Rakesh Popat, Karthik Ramasamy, Ceri A Bygrave, Tushhar Dadaga, Matthew Streetly, James Cavenagh, Mike Chapman, Sally F Barrington, Lucy Pike, Roger Owen, Laura Clifton-Hadley, Kwee L Yong
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial. British journal of haematology 192 (1) (2020)
Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham, Helen J Lachmann, Julian D Gillmore, Kwee L Yong, Neil Rabin, Rakesh Popat, Charalampia Kyriakou, Sarah Worthington, Faye A Sharpley, Mark Smith, Raakhee Shah, Simon Cheesman, Philip N Hawkins, Ashutosh D Wechalekar
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British journal of haematology 187 (5) (2019)
Gordon Cook, Kara-Louise Royle, Sheila O'Connor, David A Cairns, A John Ashcroft, Cathy D Williams, Anna Hockaday, Jamie D Cavenagh, John A Snowden, Debo Ademokun, Eleni Tholouli, Vivienne E Andrews, Matthew Jenner, Christopher Parrish, Kwee L Yong, Jim Cavet, Hannah Hunter, Jenny M Bird, Guy Pratt, Mark T Drayson, Julia M Brown, Treen C M Morris, null null
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. British journal of haematology 185 (3) (2019)
Marc-Steffen Raab, Leah Fink, Paul Schoen, Sebastian Gonzalez-McQuire, Alain Flinois, Michele Cavo, Maria-Victoria Mateos, Kwee L Yong
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016. British journal of haematology 185 (5) (2018)
Esther H L Chan, Dunnya De-Silva, Adeline H F Lin, Neil Rabin, Ashutosh Wechalekar, Rakesh Popat, Wee Joo Chng, Kwee L Yong
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres. British journal of haematology 186 (1) (2018)
Oliver C Cohen, Nicholas Counsell, Neil Rabin, Rakesh Popat, Roger G Owen, Bilyana Popova, Oliver Schofield, Laura Clifton-Hadley, Janet Lyons-Lewis, Andy Rawstron, Christopher Spence, Ruth M de Tute, Derralynn Hughes, Sally Moore, Paul Smith, Kwee L Yong
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse. British journal of haematology 185 (5) (2018)